BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9406726)

  • 1. Experimental radioimmunotargeting combining nonlabeled, iodine-125-labeled, and anti-idiotypic anticytokeratin monoclonal antibodies: a dosimetric evaluation.
    Rossi Norrlund R; Ullén A; Sandström P; Holback D; Johansson L; Stigbrand T; Hietala SO; Riklund Ahlström K
    Cancer; 1997 Dec; 80(12 Suppl):2689-98. PubMed ID: 9406726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosimetry of fractionated experimental radioimmunotargeting with idiotypic and anti-idiotypic anticytokeratin antibodies.
    Rossi Norrlund R; Ullén A; Sandström P; Holback D; Johansson L; Stigbrand T; Hietala SO; Riklund Ahlström K
    Cancer; 1997 Dec; 80(12 Suppl):2681-8. PubMed ID: 9406725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combinations of nonlabeled, 125I-labeled, and anti-idiotypic antiplacental alkaline phosphatase monoclonal antibodies at experimental radioimmunotargeting.
    Rossi Norrlund R; Holback D; Johansson L; Hietala SO; Ahlström KR
    Acta Radiol; 1997 Nov; 38(6):1087-93. PubMed ID: 9394676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetry of fractionated administration of 125I-labeled antibody at experimental radioimmunotargeting.
    Ullén A; Sandström P; Rossi Norrlund R; Rathsman S; Johansson L; Riklund Ahlström K; Hietala SO; Stigbrand T
    Cancer; 1997 Dec; 80(12 Suppl):2510-8. PubMed ID: 9406704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The combination of external beam radiotherapy and experimental radioimmunotargeting with a monoclonal anticytokeratin antibody.
    Johansson A; Eriksson D; Ullén A; Löfroth PO; Johansson L; Riklund-Ahlström K; Stigbrand T
    Cancer; 2002 Feb; 94(4 Suppl):1314-9. PubMed ID: 11877762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of complexed anticytokeratin 8 scFv TS1-218 to HeLa HEp-2 multicellular tumor spheroids and experimental tumors.
    Jafari R; Holm P; Sandegren J; Stigbrand T; Sundström BE
    Cancer Biother Radiopharm; 2010 Aug; 25(4):455-63. PubMed ID: 20707717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of anticytokeratin monoclonal anti-idiotypic antibodies to improve tumor:nontumor ratio in experimental radioimmunolocalization.
    Ullén A; Sandström P; Ahlström KR; Sundström B; Nilsson B; Arlestig L; Stigbrand T
    Cancer Res; 1995 Dec; 55(23 Suppl):5868s-5873s. PubMed ID: 7493362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability and immunoreactivity of the monoclonal anticytokeratin antibody TS1 after different degrees of iodination.
    Johansson A; Sandström P; Ullén A; Erlandsson A; Sundström B; Ahlström KR; Johansson L; Hietala SO; Stigbrand T
    Acta Oncol; 1999; 38(3):329-34. PubMed ID: 10380824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of the interactions between the anticytokeratin 8 monoclonal antibody TS1, its antigen and its anti-idiotypic antibody alphaTS1.
    Erlandsson A; Holm P; Ullén A; Stigbrand T; Sundström BE
    J Mol Recognit; 2003; 16(3):157-63. PubMed ID: 12833571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioimmunoscintigraphy with a novel monoclonal antiprostate antibody (E4): an experimental study in nude mice.
    Rydh A; Riklund Ahlström K; Widmark A; Johansson L; Nilsson S; Bergh A; Damber JE; Stigbrand T; Hietala SO
    Cancer; 1997 Dec; 80(12 Suppl):2398-403. PubMed ID: 9406689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of growth of HeLa cell tumours in nude mice by 125I-labeled anticytokeratin and antiPLAP monoclonal antibodies.
    Riklund KE; Makiya R; Sundström B; Bäck O; Henriksson R; Hietala SO; Stigbrand T
    Anticancer Res; 1991; 11(2):555-60. PubMed ID: 1712175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodistribution and dosimetric study in medullary thyroid cancer xenograft using bispecific antibody and iodine-125-labeled bivalent hapten.
    Hosono M; Hosono MN; Kraeber-Bodéré F; Devys A; Thédrez P; Fiche M; Gautherot E; Barbet J; Chatal JF
    J Nucl Med; 1998 Sep; 39(9):1608-13. PubMed ID: 9744353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radio-immunolocalization in nude mice using anticytokeratin monoclonal antibodies.
    Sundström B; Johansson B; Hietala SO; Stigbrand T
    Tumour Biol; 1990; 11(3):158-66. PubMed ID: 1693011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syngeneic anti-idiotypic antibodies eliminate excess radiolabeled idiotypes at experimental radioimmunolocalization.
    Ullén A; Riklund Ahlström K; Makiya R; Stigbrand T
    Cell Biophys; 1995 Aug; 27(1):31-45. PubMed ID: 7493397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 131I-Lym-1 in mice implanted with human Burkitt's lymphoma (Raji) tumors: loss of tumor specificity due to radiolysis.
    DeNardo GL; DeNardo SJ; Wessels BW; Kukis DL; Miyao N; Yuan A
    Cancer Biother Radiopharm; 2000 Dec; 15(6):547-60. PubMed ID: 11190487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous anti-tumor antibody responses in nude mice.
    Stigbrand T; Ullén A; Sandström P; Rathsman S; Rossi Norrlund R; Arlestig L; Riklund Ahlström K; Hietala SO
    Cancer; 1997 Dec; 80(12 Suppl):2404-10. PubMed ID: 9406690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved biodistribution of 125I-labeled anti-Tac disulfide-stabilized Fv fragment by blocking its binding to the alpha subunit of the interleukin 2 receptor in the circulation with preinjected humanized anti-Tac IgG.
    Kobayashi H; Yoo TM; Drumm D; Kim MK; Sun BF; Le N; Webber KO; Pastan I; Waldmann TA; Paik CH; Carrasquillo JA
    Cancer Res; 1997 May; 57(10):1955-61. PubMed ID: 9157991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo clearing of idiotypic antibodies with antiidiotypic antibodies and their derivatives.
    Erlandsson A; Eriksson D; Johansson L; Riklund K; Stigbrand T; Sundström BE
    Mol Immunol; 2006 Feb; 43(6):599-606. PubMed ID: 15978666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
    Buchsbaum DJ; Khazaeli MB; Mayo MS; Roberson PL
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variations in radioimmunoscintigraphic detection of tumor showed by five monoclonal antibodies to carcinoembryonic antigen.
    Kohno K; Nakata K; Kusumoto Y; Ishii N; Kohji T; Matsuoka Y; Nishi S; Nagataki S
    Ann Nucl Med; 1991 Jul; 5(2):69-75. PubMed ID: 1777353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.